menu
    • menu

    Company profile for Everest Medicines

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in the Emerging Market and have a high probability of market approval. The ...
    Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in the Emerging Market and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in Asia Pacific territories.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Everest MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    450 Lexington Ave Suite 39B New York, NY, 10017
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.everestmedicines.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Everest Medicines Acquires VIS-101, Rights For Eye Disease
    Everest Medicines Acquires VIS-101, Rights For Eye Disease

    31 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-31/everest-medicines-acquires-exclusive-greater-china-and-other-asian-country-rights-to-vis-101-a-novel-bifunctional-biologic-for-serious-eye-disorders

    PHARMIWEB
    31 Oct 2025
    Share Share
    Visara Assigns Its Exclusive License to Everest Med for VIS-101
    Visara Assigns Its Exclusive License to Everest Med for VIS-101

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176984/0/en/NovaBridge-Subsidiary-Visara-Assigns-Its-Exclusive-License-to-Everest-Medicines-for-VIS-101-in-Greater-China-and-Certain-Other-Asian-Countries.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Everest Enrolls 1st Patient In Global Ph1 Trial for EVM14 Vaccine
    Everest Enrolls 1st Patient In Global Ph1 Trial for EVM14 Vaccine

    15 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-15/everest-medicines-announces-first-patient-enrolled-in-a-global-multi-center-phase-i-clinical-trial-of-tumor-associated-antigen-cancer-vaccine-evm14

    PHARMIWEB
    15 Oct 2025
    Share Share
    Everest Medicines Publish Etrasimod's Phase III ENLIGHT UC Study
    Everest Medicines Publish Etrasimod's Phase III ENLIGHT UC Study

    09 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-09/everest-medicines-announces-publication-of-etrasimods-asian-multicenter-phase-iii-enlight-uc-study-es101002-results-in-the-lancet-gastroenterology

    PHARMIWEB
    09 Oct 2025
    Share Share
    Everest Medicines Reveals First-Half 2025 Interim Results
    Everest Medicines Reveals First-Half 2025 Interim Results

    28 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everest-medicines-announces-interim-results-for-first-half-of-2025-302541596.html

    PR NEWSWIRE
    28 Aug 2025
    Share Share
    Everest Medicines to Participate in September Investor Conference
    Everest Medicines to Participate in September Investor Conference

    25 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/everest-medicines-announces-participation-in-september-investor-conferences-302537664.html

    PR NEWSWIRE
    25 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search